OmniComm Systems Acquires EDC Assets of Logos Technologies


Company News Release

Fort Lauderdale, Florida

OmniComm Systems (Fort Lauderdale, FL) has acquired the EDC assets of UK-based Logos Technologies, who has U.S. headquarters in Arlington, VA. The acquisition will be led by OmniComm's UK subsidiary OmniComm Ltd. and provide the parent company with EDC products that cover all aspects of the Phase I process, including subject recruitment, clinical workflow management, and laboratory samplemanagement.

"We are pleased to add the Logos products and operations to the OmniComm team,” said Cornelis F. Wit,
OmniComm's President and CEO, in a company press release. "We believe that the addition of the Logos Phase I products is of importance for OmniComm Systems, as it will broaden the scope of our integrated eClinical solutions offering. Only a very small number of EDC companies specialize in the Phase I market, therefore this acquisition represents animportant addition to our overall corporate growth strategy."

OmniComm reports that the new Logos products will complement their TrialMaster software, which is primarily used in later stage clinical trials.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.